Tilting Offshore Windmills: Speaking Truth to Ratepayers

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Joe Selvaggi talks with energy economist Dr. Jonathan Lesser about the chasm between the promises and realities of offshore wind projects, including the likely increased costs passed to electricity consumers and taxpayers.

Guest:

Jonathan Lesser is an adjunct fellow at the Manhattan Institute. As president of Continental Economics, Lesser has more than 30 years of experience working for regulated utilities, for government, and as a consultant in the energy industry. He has addressed economic and regulatory issues affecting energy in the U.S., Canada, and Latin America. Those issues include gas and electric utility structure and operations, generating asset valuation under uncertainty, cost-benefit analysis, mergers and acquisitions, cost allocation and rate design, resource investment-decision strategies, cost of capital, depreciation, risk management, incentive regulation, economic impact studies, and energy and environmental policies.

WATCH:

Recent Episodes

Farmers Welfare Bill: Rethinking Costly and Environmentally Distortive Subsidies

Joe Selvaggi discusses the cost and consequences of the $1.5 trillion decade-long subsidies in the farm bill with Chris Edwards, Chair of Fiscal Studies at the Cato Institute. These subsidies have the potential to negatively impact incentives for consumers, producers, and those concerned about the environment.

Predatory Tax Ruling: Supreme Court Closes Door on Home Equity Theft

Joe Selvaggi talks with Pacific Legal Foundation’s state legal policy deputy, attorney Jim Manley, about home equity theft, a practice that has taken 350 properties in Massachusetts, dispossessing homeowners of more than $50 million in equity.

Sweden’s Pandemic Paradigm: Does Trust in Citizenry Save Lives

Joe Selvaggi talks with Johan Norberg, author and senior fellow at CATO Institute, about his analysis of Sweden’s resistance to government-mandated COVID-19 control measures, as well as Sweden’s public health outcomes relative to the U.S and peer nations.

Breast Cancer Risk: Testing to Tailored Screening, Treatment, and Prevention

Joe Selvaggi talks with precision medicine expert, Alva 10 CEO Hannah Mamuszka about how individualized testing can both detect and substantially reduce the incidence of breast cancer, a disease that accounts for more than 40k deaths each year.